Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Spruce Biosciences Inc (NQ: SPRB )

2.430 +0.030 (+1.25%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 39,401
Open 2.430
Bid (Size) 2.400 (1)
Ask (Size) 2.500 (6)
Prev. Close 2.400
Today's Range 2.350 - 2.480
52wk Range 0.9547 - 3.570
Shares Outstanding 39,746,116
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Spruce Biosciences Appoints Percival Barretto-Ko to Board of Directors
From Spruce Biosciences, Inc.
Via Business Wire
Spruce Biosciences to Participate in the Jefferies Healthcare Conference
From Spruce Biosciences, Inc.
Via Business Wire

Performance

YTD
+111.30%
+111.30%
1 Month
+16.27%
+16.27%
3 Month
+7.05%
+7.05%
6 Month
+120.91%
+120.91%
1 Year
+55.77%
+55.77%

More News

Read More
Spruce Biosciences Honored at CARES Foundation 15th Annual Everyone CARES Gala
From Spruce Biosciences, Inc.
Via Business Wire
Analyst Expectations for Spruce Biosciences's Future
Via Benzinga
4 Analysts Have This to Say About Spruce Biosciences
Via Benzinga
Spruce Biosciences Reports First Quarter 2023 Financial Results and Provides Corporate Updates
From Spruce Biosciences, Inc.
Via Business Wire
Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting
From Spruce Biosciences, Inc.
Via Business Wire
Spruce Biosciences to Participate in May Investor Conferences
From Spruce Biosciences, Inc.
Via Business Wire
89bio To Rally 265%? Here Are 10 Other Analyst Forecasts For Thursday
Via Benzinga
Spruce Biosciences Reports Full Year 2022 Financial Results and Provides Corporate Updates
From Spruce Biosciences, Inc.
Via Business Wire
Spruce Biosciences to Participate in the Oppenheimer 33rd Annual Healthcare Conference
From Spruce Biosciences, Inc.
Via Business Wire
$7M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Buying
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Spruce Biosciences Announces $53.6 Million Private Placement Financing
From Spruce Biosciences, Inc.
Via Business Wire
Spruce Biosciences to Participate in the SVB Securities Global Biopharma Conference
From Spruce Biosciences, Inc.
Via Business Wire
Peering Into Spruce Biosciences's Recent Short Interest
Via Benzinga
Spruce Biosciences Provides Clinical Program Updates and Outlines Anticipated Milestones for 2023
From Spruce Biosciences, Inc.
Via Business Wire
Why CinCor Pharma Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Dow Jumps 700 Points; S&P 500 Rises Over 2%
Via Benzinga
Spruce Biosciences (NASDAQ: SPRB) Enters Into Collaboration with Kaken Pharmaceutical to Develop Tildacerfont for CAH in Japan
Via Spotlight Growth
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Nasdaq Gains 1.5%; Fate Therapeutics Shares Plunge
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.